Bliss Kelly 4

What Happened
Bliss Kelly, President, U.S. Group Health at Teladoc Health (TDOC), converted multiple performance/restricted stock unit awards into common shares on June 1, 2026, and then sold 7,679 shares in an open-market transaction on June 2, 2026 at $7.63 per share for total proceeds of $58,568. The Form 4 also reports conversion/exercise entries of 1,300, 4,858 and 9,152 shares on June 1 that are shown as disposals at $0 (see footnotes).

Key Details

• Transaction dates: June 1, 2026 (conversion/exercise of derivatives) and June 2, 2026 (open-market sale).
• Open-market sale: 7,679 shares @ $7.63 = $58,568.
• Conversions/exercises reported: 1,300; 4,858; 9,152 shares (each listed as acquired via derivative exercise on 6/1 and also listed as disposed at $0).
• Footnotes of note:
  • F1/F2: Performance and restricted stock units convert 1:1 into common shares.
  • F3: Shares were sold to cover tax withholding related to vesting.
  • F4–F6: Detail prior PSU/RSU grants and vesting schedules relevant to these conversions.
• Shares owned after the transactions: not stated in the provided excerpt of the filing.
• Filing date: June 3, 2026 — filed within the normal Form 4 window (timely).

Context
The June 1 entries reflect conversion/vesting of equity awards (derivative exercises) rather than a cash purchase. The $0 disposals typically indicate shares withheld or transferred to cover tax withholding on vesting, per the footnotes; the separate June 2 sale was an open-market sale generating $58.6K. These items are routine insider transactions related to vesting and tax obligations rather than a straightforward buy signal.